Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an update.
ResMed Inc. has announced its 2025 Annual Meeting, scheduled for November 19, 2025, in the US and November 20, 2025, in Australia. The meeting will be conducted virtually, allowing shareholders to participate and vote on various proposals. This announcement is significant as it emphasizes the company’s commitment to shareholder engagement and transparency, providing stakeholders with the opportunity to influence corporate governance and strategic decisions.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$47.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, primarily focusing on the development and manufacturing of products for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company is known for its innovative solutions in medical devices and cloud-connected software applications, aiming to improve patient outcomes and reduce healthcare costs.
Average Trading Volume: 1,037,884
Technical Sentiment Signal: Buy
Current Market Cap: A$59.91B
See more insights into RMD stock on TipRanks’ Stock Analysis page.